Literature DB >> 26697843

Rev7/Mad2B plays a critical role in the assembly of a functional mitotic spindle.

Audesh Bhat1, Zhaojia Wu1, Veronica M Maher2, J Justin McCormick2, Wei Xiao1,3.   

Abstract

The spindle assembly checkpoint (SAC) acts as a guardian against cellular threats that may lead to chromosomal missegregation and aneuploidy. Mad2, an anaphase-promoting complex/cyclosome-Cdc20 (APC/C(Cdc20)) inhibitor, has an additional homolog in mammals known as Mad2B, Mad2L2 or Rev7. Apart from its role in Polζ-mediated translesion DNA synthesis and double-strand break repair, Rev7 is also believed to inhibit APC/C by negatively regulating Cdh1. Here we report yet another function of Rev7 in cultured human cells. Rev7, as predicted earlier, is involved in the formation of a functional spindle and maintenance of chromosome segregation. In the absence of Rev7, cells tend to arrest in G2/M-phase and display increased monoastral and abnormal spindles with misaligned chromosomes. Furthermore, Rev7-depleted cells show Mad2 localization at the kinetochores of metaphase cells, an indicator of activated SAC, coupled with increased levels of Cyclin B1, an APC(Cdc20) substrate. Surprisingly unlike Mad2, depletion of Rev7 in several cultured human cell lines did not compromise SAC activity. Our data therefore suggest that besides its role in APC/C(Cdh1) inhibition, Rev7 is also required for mitotic spindle organization and faithful chromosome segregation most probably through its physical interaction with RAN.

Entities:  

Keywords:  Mad2; RAN; Rev7/Mad2B; aneuploidy; mitosis; spindle assembly checkpoint

Mesh:

Substances:

Year:  2015        PMID: 26697843      PMCID: PMC4825701          DOI: 10.1080/15384101.2015.1120922

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  46 in total

1.  Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins.

Authors:  J D Reimann; B E Gardner; F Margottin-Goguet; P K Jackson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

2.  A novel binding protein of single-minded 2: the mitotic arrest-deficient protein MAD2B.

Authors:  Xianfang Meng; Xiujuan Tian; Xiaolan Wang; Pan Gao; Chun Zhang
Journal:  Neurogenetics       Date:  2012-06-02       Impact factor: 2.660

3.  Nuclear localization of the cell cycle regulator CDH1 and its regulation by phosphorylation.

Authors:  Yuan Zhou; Yick-Pang Ching; Abel C S Chun; Dong-Yan Jin
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

4.  Analysis of the spindle-assembly checkpoint in HeLa cells.

Authors:  Paul R Andreassen; Dimitrios A Skoufias; Robert L Margolis
Journal:  Methods Mol Biol       Date:  2004

5.  MAD2B is an inhibitor of the anaphase-promoting complex.

Authors:  J Chen; G Fang
Journal:  Genes Dev       Date:  2001-07-15       Impact factor: 11.361

6.  Interactions in the error-prone postreplication repair proteins hREV1, hREV3, and hREV7.

Authors:  Y Murakumo; Y Ogura; H Ishii; S Numata; M Ichihara; C M Croce; R Fishel; M Takahashi
Journal:  J Biol Chem       Date:  2001-08-02       Impact factor: 5.157

7.  Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells.

Authors:  Loren Michel; Elena Diaz-Rodriguez; Gopeshwar Narayan; Eva Hernando; Vundavalli V V S Murty; Robert Benezra
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

8.  Structure and enzymatic properties of a stable complex of the human REV1 and REV7 proteins.

Authors:  Yuji Masuda; Mika Ohmae; Kenji Masuda; Kenji Kamiya
Journal:  J Biol Chem       Date:  2003-01-15       Impact factor: 5.157

9.  REV7 counteracts DNA double-strand break resection and affects PARP inhibition.

Authors:  J Ross Chapman; Inger Brandsma; Guotai Xu; Jingsong Yuan; Martin Mistrik; Peter Bouwman; Jirina Bartkova; Ewa Gogola; Daniël Warmerdam; Marco Barazas; Janneke E Jaspers; Kenji Watanabe; Mark Pieterse; Ariena Kersbergen; Wendy Sol; Patrick H N Celie; Philip C Schouten; Bram van den Broek; Ahmed Salman; Marja Nieuwland; Iris de Rink; Jorma de Ronde; Kees Jalink; Simon J Boulton; Junjie Chen; Dik C van Gent; Jiri Bartek; Jos Jonkers; Piet Borst; Sven Rottenberg
Journal:  Nature       Date:  2015-03-23       Impact factor: 49.962

10.  Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2.

Authors:  V Sudakin; G K Chan; T J Yen
Journal:  J Cell Biol       Date:  2001-09-03       Impact factor: 10.539

View more
  13 in total

1.  A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy.

Authors:  Jessica L Wojtaszek; Nimrat Chatterjee; Javaria Najeeb; Azucena Ramos; Minhee Lee; Ke Bian; Jenny Y Xue; Benjamin A Fenton; Hyeri Park; Deyu Li; Michael T Hemann; Jiyong Hong; Graham C Walker; Pei Zhou
Journal:  Cell       Date:  2019-06-06       Impact factor: 41.582

2.  Hematopoietic PBX-interacting protein is a substrate and an inhibitor of the APC/C-Cdc20 complex and regulates mitosis by stabilizing cyclin B1.

Authors:  Saratchandra Singh Khumukcham; Venkata Subramanyam Kumar Samanthapudi; Vasudevarao Penugurti; Anita Kumari; P S Kesavan; Loka Reddy Velatooru; Siva Reddy Kotla; Aprotim Mazumder; Bramanandam Manavathi
Journal:  J Biol Chem       Date:  2019-05-17       Impact factor: 5.157

3.  Identification of the first small-molecule inhibitor of the REV7 DNA repair protein interaction.

Authors:  Marcelo L Actis; Nigus D Ambaye; Benjamin J Evison; Youming Shao; Murugendra Vanarotti; Akira Inoue; Ezelle T McDonald; Sotaro Kikuchi; Richard Heath; Kodai Hara; Hiroshi Hashimoto; Naoaki Fujii
Journal:  Bioorg Med Chem       Date:  2016-07-16       Impact factor: 3.641

4.  Dynamic feature of mitotic arrest deficient 2-like protein 2 (MAD2L2) and structural basis for its interaction with chromosome alignment-maintaining phosphoprotein (CAMP).

Authors:  Kodai Hara; Shota Taharazako; Masanori Ikeda; Hiroki Fujita; Yoshiko Mikami; Sotaro Kikuchi; Asami Hishiki; Hideshi Yokoyama; Yoshinobu Ishikawa; Shin-Ichiro Kanno; Kozo Tanaka; Hiroshi Hashimoto
Journal:  J Biol Chem       Date:  2017-09-08       Impact factor: 5.157

Review 5.  REV7: Jack of many trades.

Authors:  Inge de Krijger; Vera Boersma; Jacqueline J L Jacobs
Journal:  Trends Cell Biol       Date:  2021-05-04       Impact factor: 20.808

6.  SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice.

Authors:  Steven Findlay; John Heath; Vincent M Luo; Abba Malina; Théo Morin; Yan Coulombe; Billel Djerir; Zhigang Li; Arash Samiei; Estelle Simo-Cheyou; Martin Karam; Halil Bagci; Dolev Rahat; Damien Grapton; Elise G Lavoie; Christian Dove; Husam Khaled; Hellen Kuasne; Koren K Mann; Kathleen Oros Klein; Celia M Greenwood; Yuval Tabach; Morag Park; Jean-Francois Côté; Jean-Yves Masson; Alexandre Maréchal; Alexandre Orthwein
Journal:  EMBO J       Date:  2018-08-28       Impact factor: 11.598

Review 7.  Translesion Synthesis in Plants: Ultraviolet Resistance and Beyond.

Authors:  Ayako N Sakamoto
Journal:  Front Plant Sci       Date:  2019-10-09       Impact factor: 5.753

8.  REV7 is required for processing AID initiated DNA lesions in activated B cells.

Authors:  Dingpeng Yang; Ying Sun; Jingjing Chen; Ying Zhang; Shuangshuang Fan; Min Huang; Xia Xie; Yanni Cai; Yafang Shang; Tuantuan Gui; Liming Sun; Jiazhi Hu; Junchao Dong; Leng-Siew Yeap; Xiaoming Wang; Wei Xiao; Fei-Long Meng
Journal:  Nat Commun       Date:  2020-06-04       Impact factor: 14.919

9.  Involvement of AMPK in regulating the degradation of MAD2B under high glucose in neuronal cells.

Authors:  Xianfang Meng; Guangpin Chu; Chen Ye; Hui Tang; Ping Qiu; Yue Hu; Man Li; Chun Zhang
Journal:  J Cell Mol Med       Date:  2016-12-13       Impact factor: 5.310

10.  Mitotic Arrest-Deficient Protein 2B Overexpressed in Lung Cancer Promotes Proliferation, EMT, and Metastasis.

Authors:  Hua Zhang; Xiuquan He; Wenfei Yu; Bingqing Yue; Ziting Yu; Ying Qin
Journal:  Oncol Res       Date:  2017-09-11       Impact factor: 5.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.